10x Genomics Q1 EPS Estimate Decreased by Leerink Partnrs
10x Genomics, Inc. (NASDAQ:TXG – Free Report) – Analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of 10x Genomics in a research note issued to investors on Thursday, February 13th. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings of ($0.54) per share for the quarter, down […]
10x Genomics, Inc. (NASDAQ:TXG – Free Report) – Analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of 10x Genomics in a research note issued to investors on Thursday, February 13th. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings of ($0.54) per share for the quarter, down […]
